£17.65 – £68.38
Buy GHRP-6 CJC-1295 DAC Blend Peptide Vial 2.5mg and 10mg
This product is a blend of the GHRP-6 which binds the secretagogue growth hormone, and the CJC-1295 which binds the growth hormone that releases the GHRH hormone receptor.
2.5mg Vial: CJC-1295 = 0.8mg | GHRP-6 = 1.7mg
10mg Vial: CJC-1295 = 5mg | GHRP-6 = 5mg
479 in stock
This product is intended for research purposes only. To be used by trained professionals only.
Buy GHRP-6 CJC-1295 DAC Blend Peptide Vial (2.5mg), a synergistic combination of two potent peptides, designed to enhance growth hormone release and promote overall anabolic effects.
GHRP-6, or Growth Hormone Releasing Peptide-6, is known for its ability to stimulate the pituitary gland, thereby increasing endogenous growth hormone production. This peptide contributes to muscle gain, fat loss, and improved recovery times.
When combined with CJC-1295 DAC, which prolongs the effects of growth hormone due to its extended half-life, the blend maximises the benefits associated with both peptides. The 2.5mg dosage offers an effective solution for researchers focusing on muscle development, metabolic improvement, and advanced recovery protocols.
This blend has gained attention for its potential to enhance performance and wellness, making it a valuable addition to studies in the fields of sports science and anti-aging research.
To discover more information about the individual peptides including the mechanisms of action, benefits, side effects and available products offered by Direct Peptides Australia, visit the main category pages:
Synergistic Action: Combines the effects of GHRP-6 and CJC-1295 DAC for enhanced growth hormone release.
Increases Endogenous Growth Hormone Production: GHRP-6 stimulates the pituitary gland, leading to increased natural growth hormone levels.
Supported Muscle Gain: Promotes significant muscle development and strength through enhanced anabolic activity.
Facilitates Fat Loss: Aids in reducing body fat while supporting lean muscle mass retention.
Improved Recovery Times: Speeds up recovery from exercise-related fatigue and injury.
Prolonged Effects: CJC-1295 DAC extends the duration of growth hormone benefits due to its longer half-life.
Optimised Research Tool: The 2.5mg dosage is specifically selected for effective results in research settings focusing on performance and metabolic health.
Versatile Applications: Suitable for studies in sports science, anti-aging research, and other areas exploring growth hormone dynamics.
Shop our full range of Australia Peptide Blends here.
The GHRP-6 and CJC-1295 DAC Blend (2.5mg and 10mg) is carefully packaged to ensure the integrity of the peptides during transit, with temperature-controlled shipping methods employed to maintain potency and efficacy until it reaches the end user.
To ensure the stability and potency of the GHRP-6 and CJC-1295 DAC Blend, it should be stored in a cool, dry place at a controlled temperature between 2°C and 8°C, avoiding exposure to direct sunlight and extreme temperatures.
Reconstituting the GHRP-6 and CJC-1295 DAC Blend (2.5mg and 10mg) is crucial for safe peptide administration. Gather necessary materials, ensure cleanliness, and wipe the vial’s stopper with an alcohol swab. Use a sterile syringe to draw 1-2ml of bacteriostatic water or saline and slowly inject it into the vial without frothing the powder.
Gently swirl to dissolve and confirm no particles remain. Store the reconstituted blend at 2°C to 8°C and document the reconstitution date for tracking in research studies.
At Direct Peptides Australia, you can obtain premium peptide supplies tailored to your research needs. Our carefully selected supplies includes syringes, empty cartridges, and a pen needle pack, all designed to ensure the efficient reconstitution of your peptides.
References:
[1] M Granado, C García-Cáceres, L M Frago, J Argente, and J A Chowen (2010) The Positive Effects of Growth Hormone-Releasing Peptide-6 on Weight Gain and Fat Mass Accrual Depend on the Insulin/Glucose Status – Endocrinology, Volume 151, Issue 5, 1 May 2010, Pages 2008–2018.
[2] M Alba, D Fintini, A Sagazio, B Lawrence, JP Castaigne, L A Frohman, R Salvatori (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology. Endocrinology and Metabolism, 2006 Dec, Volume 291 (Issue 6), Pages E1290-4.
[3] A V Schally, X Zhang, R Cai, J M Hare, R Granata, and M Bartoli (2019) Actions and Potential Therapeutic Applications of Growth Hormone–Releasing Hormone Agonists – Endocrinology, Volume 160, Issue 7, July 2019, Pages 1600–1612.
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Australia Direct Peptides website: https://australia.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
BUY GHRP-6 CJC-1295 DAC Blend Peptide Vial ONLINE Today From Australia Direct Peptides
401 N. Mills Ave, Ste B, Orlando, FL 32803, United States
